Bausch + Lomb Corporation

NYSE (USD): Bausch + Lomb Corporation (BLCO)

Last Price

18.00

Today's Change

+0.05 (0.27%)

Day's Change

17.85 - 18.20

Trading Volume

393,257

Profile
BLCO

Exchange:  New York Stock Exchange New York Stock Exchange

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Brenton L. Saunders J.D. Mr. Brenton L. Saunders J.D.

Full Time Employees:  13,000 13,000

IPO Date:  2022-05-06 2022-05-06

CIK:  0001860742 0001860742

ISIN:  CA0717051076 CA0717051076

CUSIP:  071705107 071705107

Beta:  0.46 0.46

Last Dividend:  0.00 0.00

Dcf Diff:  -3.14 -3.14

Dcf:  21.14 21.14

Description

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Address

520 Applewood Crescent,
Vaughan, ON L4K 4B4, CA

905 695 7700

http://www.bausch.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment